{"id":27461,"date":"2026-11-20T06:29:54","date_gmt":"2026-11-20T06:29:54","guid":{"rendered":"https:\/\/thestrategystory.com\/blog\/medibank-private-business-model-2026\/"},"modified":"2026-11-20T06:30:39","modified_gmt":"2026-11-20T06:30:39","slug":"medibank-private-business-model-2026","status":"publish","type":"post","link":"https:\/\/thestrategystory.com\/blog\/medibank-private-business-model-2026\/","title":{"rendered":"Medibank Private Business Model in 2026"},"content":{"rendered":"<p>Medibank Private Limited (ASX: MPL) is an Australian health insurer and healthcare services provider. This Business Model analysis uses the company&#8217;s FY2025 Annual Report for all reported financial information. Figures are in Australian dollars.<\/p>\n<h2>1. Overview: an insurer and a healthcare services provider<\/h2>\n<p>Medibank Private Limited is an Australian health company whose central business is underwriting private health insurance. Its two principal insurance brands, Medibank and ahm, serve customers with different preferences for cover, service and price. The FY2025 annual report says the company provided health insurance to more than 4.2 million people. The insurance business pools premiums across policyholders and pays eligible healthcare claims under policy terms. The company also operates health services through Medibank Health and Amplar Health, including prevention, primary care, homecare and interests in short-stay surgical and mental health facilities.<\/p>\n<p>The two businesses have complementary but different economics. Insurance collects premiums in exchange for bearing defined healthcare costs. Healthcare services earn revenue by providing or arranging care, with profitability depending on service volumes, staffing, clinical quality and contracts. Owning or partnering with care providers may improve the customer experience and help create alternatives to traditional hospital settings, but it also adds operational and clinical responsibilities. Medibank&#8217;s strategy is therefore broader than selling policies: it aims to influence how customers access care while retaining the financial discipline required of an insurer.<\/p>\n<p>Scale is important because claims can vary materially between individuals and periods. A large customer pool can diversify some risks and support investment in technology, service and healthcare partnerships. However, scale does not eliminate medical inflation, regulatory requirements or customer switching. In a market where households scrutinise premiums, Medibank must demonstrate that its products deliver useful protection and service rather than relying on brand recognition alone.<\/p>\n<p><strong>Related reading:<\/strong> <a href=\"https:\/\/thestrategystory.com\/blog\/medibank-private-business-strategy-2026\/\">Business Strategy<\/a> | <a href=\"https:\/\/thestrategystory.com\/blog\/medibank-private-swot-analysis-2026\/\">SWOT Analysis<\/a> | <a href=\"https:\/\/thestrategystory.com\/blog\/medibank-private-pestel-analysis-2026\/\">PESTEL Analysis<\/a>.<\/p>\n<h2>2. Customer problem and the Medibank\u2013ahm proposition<\/h2>\n<p>Australian customers buy private health insurance to help manage eligible hospital and extras expenses and obtain access to certain private healthcare options. Their decisions involve trade-offs among premiums, excesses, exclusions, waiting periods, provider choice and expected use. A household with different needs may rationally choose a lower-premium policy rather than comprehensive cover. Medibank and ahm allow the group to address distinct customer segments while sharing underwriting and operational capabilities. The brands compete for both new policyholders and renewals, so customer experience matters throughout the relationship.<\/p>\n<p>The annual report identifies cost-of-living pressure and competitive dynamics as significant factors in the resident insurance market. These pressures affect whether customers retain cover, switch products or reduce their level of protection. For the insurer, acquisition growth can be less valuable if new customers leave quickly or carry a claims profile that is poorly reflected in pricing. The commercial objective is not simply the maximum number of policies. It is sustainable growth with appropriate benefits, fair claims outcomes, manageable service costs and a relationship customers want to maintain.<\/p>\n<p>Medibank also offers diversified insurance products including travel, life, home and pet insurance, but these should not be confused with its core health underwriting economics. Cross-selling can increase customer engagement, yet products must be assessed for their own margins and partner arrangements. The Live Better rewards programme supports health and wellbeing engagement; its strategic value depends on whether customers participate, perceive value and develop stronger relationships with the brands.<\/p>\n<p><strong>Related reading:<\/strong> <a href=\"https:\/\/thestrategystory.com\/blog\/medibank-private-business-strategy-2026\/\">Business Strategy<\/a> | <a href=\"https:\/\/thestrategystory.com\/blog\/medibank-private-swot-analysis-2026\/\">SWOT Analysis<\/a> | <a href=\"https:\/\/thestrategystory.com\/blog\/medibank-private-pestel-analysis-2026\/\">PESTEL Analysis<\/a>.<\/p>\n<h2>3. How health insurance makes money<\/h2>\n<p>The FY2025 annual report reported premium revenue of A$8,211.0 million on the management basis used for health insurance performance. Net claims expense, including risk equalisation, was A$6,814.6 million, producing gross profit of A$1,396.4 million. Management expenses were A$654.9 million, leaving health insurance operating profit of A$741.5 million. Gross margin was 17.0%, the management expense ratio 8.0% and operating margin 9.0%. These figures demonstrate the central underwriting equation: premiums must cover claims, acquisition and administration costs while leaving an appropriate return.<\/p>\n<p>Risk equalisation is important because insurers do not all have identical member age or risk profiles. It redistributes some claims costs across the industry under Australian arrangements, affecting the economics of attracting and retaining different customer groups. The company must also manage hospital and extras utilisation, negotiated provider arrangements, benefit design and fraud controls. Cost control should not be interpreted as simply denying legitimate care. Poor claims experience or unclear products can damage customer trust and increase churn, weakening the longer-term franchise.<\/p>\n<p>Financial reporting requires careful definitions. Under AASB 17, insurance revenue recognised in statutory statements was A$8,011.7 million, which differs from management-basis premium revenue of A$8,211.0 million. They are not interchangeable. The statutory income statement also includes insurance service expenses and an insurance service result. An analyst comparing revenue and margins must use consistent denominators and account for the presentation differences rather than treating the two reported amounts as an error.<\/p>\n<p><strong>Related reading:<\/strong> <a href=\"https:\/\/thestrategystory.com\/blog\/medibank-private-business-strategy-2026\/\">Business Strategy<\/a> | <a href=\"https:\/\/thestrategystory.com\/blog\/medibank-private-swot-analysis-2026\/\">SWOT Analysis<\/a> | <a href=\"https:\/\/thestrategystory.com\/blog\/medibank-private-pestel-analysis-2026\/\">PESTEL Analysis<\/a>.<\/p>\n<h2>4. Medibank Health and Amplar Health economics<\/h2>\n<p>Medibank Health provides services that complement the insurance operation, including prevention, primary care, virtual and home-based services and investments in selected healthcare facilities. Its FY2025 segment profit was A$76.7 million, up from A$60.4 million in FY2024. The annual report describes an organic operating profit of A$64.7 million and a 19.1% operating margin for the relevant organic services activities, with improvement partly supported by operating efficiency and scale. These are distinct management measures and should not be conflated with group profit.<\/p>\n<p>The strategic logic is that healthcare may be delivered in more convenient and cost-effective settings when clinically appropriate. Virtual consultations, homecare and integrated care pathways can improve access and may reduce unnecessary use of higher-cost settings. However, such outcomes depend on patient suitability, clinical governance, staffing, service quality and contractual arrangements with payors. A healthcare service cannot be evaluated solely by financial margin. Safety, outcomes and continuity of care are essential to long-term viability.<\/p>\n<p>The company has also used investments and acquisitions to broaden capabilities. Acquisitions may add geographic coverage, care modalities or clinical teams, but integration is difficult when care is delivered through people-intensive operations. Medibank must preserve professional standards while improving scheduling, technology, referrals and administration. Growth in health services could diversify earnings away from insurance underwriting, although its scale remains smaller than the core insurance business.<\/p>\n<p><strong>Related reading:<\/strong> <a href=\"https:\/\/thestrategystory.com\/blog\/medibank-private-business-strategy-2026\/\">Business Strategy<\/a> | <a href=\"https:\/\/thestrategystory.com\/blog\/medibank-private-swot-analysis-2026\/\">SWOT Analysis<\/a> | <a href=\"https:\/\/thestrategystory.com\/blog\/medibank-private-pestel-analysis-2026\/\">PESTEL Analysis<\/a>.<\/p>\n<h2>5. Group earnings, investments and distributions<\/h2>\n<p>Medibank reported FY2025 group revenue from external customers of A$8,604.0 million in its management summary and revenue excluding net investment income from ordinary activities of A$8,346.4 million in its Appendix 4E. These totals use different presentations and should not be casually combined. Group operating profit was A$762.4 million, up 8.9%, while net investment income was A$207.8 million. Net profit after tax attributable to shareholders was A$500.8 million, up 1.7%. Underlying NPAT, adjusted for specified investment and COVID-19 reserve effects, was A$618.7 million, up 8.5%.<\/p>\n<p>The gap between operating performance, statutory profit and underlying profit matters. FY2025 included a A$182.8 million pre-tax movement in the COVID-19 reserve and A$39.7 million in cybercrime costs. The company has continued to incur expenses associated with the 2022 cybercrime incident, making data security and customer trust financially material. Investment returns can also change with market conditions. A single profit figure therefore cannot capture all the forces affecting shareholder earnings.<\/p>\n<p>Dividends totalled 18.0 Australian cents per share for FY2025, compared with 16.6 cents in FY2024. The annual report reports an approximately 80.1% dividend payout ratio based on underlying NPAT. The ability to distribute earnings depends on regulatory capital, insurance liabilities, investment assets and growth requirements. Medibank cannot responsibly treat premiums received as unrestricted cash available for dividends, because it must meet future claims and prudential obligations.<\/p>\n<p><strong>Related reading:<\/strong> <a href=\"https:\/\/thestrategystory.com\/blog\/medibank-private-business-strategy-2026\/\">Business Strategy<\/a> | <a href=\"https:\/\/thestrategystory.com\/blog\/medibank-private-swot-analysis-2026\/\">SWOT Analysis<\/a> | <a href=\"https:\/\/thestrategystory.com\/blog\/medibank-private-pestel-analysis-2026\/\">PESTEL Analysis<\/a>.<\/p>\n<h2>6. Future model: care access, trust and disciplined growth<\/h2>\n<p>The long-term opportunity is to combine insurance distribution, customer relationships and healthcare services into a more connected model. Medibank&#8217;s stated priorities include scaling primary and virtual care, strengthening corporate health and wellbeing services, improving health outcomes and expanding access to appropriate care. These initiatives may help differentiate the group from competitors whose offerings centre mainly on insurance products. Yet the commercial benefit must be demonstrated through customer retention, service utilisation, clinical outcomes and sustainable returns, not assumed from the size of the healthcare market.<\/p>\n<p>The insurance business still faces premium affordability pressure, medical cost inflation, changes in utilisation and competitive switching. Technology can reduce administration and improve digital service, but cyber resilience and privacy protections are non-negotiable. Medibank&#8217;s FY2025 investment in digital and technology capability and marketing illustrates the trade-off between current expense efficiency and future growth. A stronger customer proposition may justify expenditure, but management must monitor whether it produces improved retention, acquisition economics and service quality.<\/p>\n<p>Medibank&#8217;s 2026 business model is best understood as a regulated insurance franchise with a growing care-services platform. The insurance operation provides scale and recurring premium relationships; the health services business offers new ways to support customers and earn service revenue. Sustainable value depends on appropriate pricing, claims management, regulatory capital, clinical quality, information security and thoughtful investment. The company must balance shareholders&#8217; expectations with its obligations to policyholders and patients.<\/p>\n<p><strong>Related reading:<\/strong> <a href=\"https:\/\/thestrategystory.com\/blog\/medibank-private-business-strategy-2026\/\">Business Strategy<\/a> | <a href=\"https:\/\/thestrategystory.com\/blog\/medibank-private-swot-analysis-2026\/\">SWOT Analysis<\/a> | <a href=\"https:\/\/thestrategystory.com\/blog\/medibank-private-pestel-analysis-2026\/\">PESTEL Analysis<\/a>.<\/p>\n<h3>Insurance risk pooling and pricing discipline<\/h3>\n<p>Health insurance works because many customers contribute premiums while only some incur large claims in a given period. This creates a responsibility to estimate expected costs accurately and maintain sufficient capital for adverse outcomes. Premium pricing reflects benefits, expected utilisation, demographics and other permissible factors within Australia&#8217;s regulatory framework. Risk equalisation changes the distribution of certain claims costs across insurers and is therefore an important element of the economic model. A strong premium base is not automatically profitable if claims rise faster than revenue. Conversely, an unusually favourable claims year should not be treated as a permanent margin improvement. Management must evaluate experience over time, including delayed treatment and changing patterns of healthcare utilisation.<\/p>\n<p>Medibank&#8217;s FY2025 gross insurance margin of 17.0% is measured on a management basis. The group reported a 50-basis-point improvement, supported by a more favourable risk equalisation outcome and higher-margin non-resident growth. That result illustrates the interaction of pricing, customer mix and industry mechanisms. It does not mean the same improvement will recur. Underwriting quality requires forecasting, appropriate reserves, careful product design and a willingness to explain coverage clearly to customers.<\/p>\n<h3>The importance of resident and non-resident portfolios<\/h3>\n<p>The resident market and non-resident insurance markets can have different customer acquisition channels, tenure and claims profiles. International students and visitors may buy cover because of visa or other requirements, while resident households make longer-term decisions about hospital and extras benefits. These differences affect the economics of pricing, commissions, retention and service. The FY2025 report notes a benefit to gross margin from the growth of higher-margin non-resident policies. However, student acquisition can respond to migration and education policy, and shorter tenure can affect acquisition economics.<\/p>\n<p>A diversified customer mix can help earnings, but only if management understands the underlying drivers. The business should track policyholder growth by segment, net retention, average premium, claims utilisation and cost of acquisition. A rise in total policy numbers may conceal weaker performance in a particular group. The two-brand strategy also needs discipline: Medibank and ahm should offer differentiated value without creating unnecessary internal cannibalisation or confusing product choices.<\/p>\n<h3>Provider relationships and the cost of care<\/h3>\n<p>A health insurer&#8217;s claims experience depends partly on the prices and utilisation of services delivered by hospitals, medical practitioners and allied health providers. Medibank does not control all of these costs. It can negotiate arrangements, design benefits and support appropriate care pathways, but clinical decisions and regulatory requirements place limits on purely financial optimisation. The economics of hospital treatment differ from dental, optical or physiotherapy benefits, and customers&#8217; claims patterns vary across age groups and policy tiers.<\/p>\n<p>Good provider relationships can improve customer access and cost predictability. Poor arrangements can create unexpected out-of-pocket expenses, limited choice or service disputes. The insurer must balance affordable premiums with adequate access to appropriate care. When Medibank develops its own healthcare services, it must also manage conflicts of interest transparently: care recommendations should be clinically appropriate and not simply designed to redirect claims toward affiliated providers.<\/p>\n<h3>Why customer retention is financially important<\/h3>\n<p>Insurance customer acquisition often requires marketing, distribution commissions and onboarding expenditure. A customer who stays longer allows these costs to be recovered across more policy periods, subject to claims and servicing costs. Retention therefore influences lifetime value. But retaining customers through confusing cancellation processes or poorly understood exclusions would undermine trust and invite regulatory risk. Medibank needs to earn loyalty through useful cover, service and fair treatment.<\/p>\n<p>Customer experience can also affect claims costs indirectly. Clear digital guidance may help members understand waiting periods and eligible services before treatment. Preventative engagement may improve wellbeing, but not every programme delivers immediate measurable savings. The company should distinguish customer satisfaction from actual health outcomes and from financial return. These measures can reinforce one another but should not be treated as equivalent.<\/p>\n<h3>Health services growth and the payer-provider boundary<\/h3>\n<p>Medibank&#8217;s healthcare businesses may serve insured members, other private payors and public systems. This broadens the potential customer base beyond Medibank policyholders. Yet it also creates a boundary between underwriting decisions and clinical service provision. The insurer bears defined claims risk; the service provider must deliver care at a cost and quality consistent with its contracts. In homecare or virtual services, staffing availability and patient suitability can be decisive constraints. Scaling quickly without sufficient clinical oversight can harm patients and reputation.<\/p>\n<p>Management should evaluate service-line profitability, utilisation, referral patterns, clinician retention and patient outcomes. The FY2025 growth in Medibank Health segment profit demonstrates progress, but the segment remains materially smaller than Health Insurance. Acquisitions can add capability, yet purchase prices, integration spending and ongoing capital needs determine whether they improve shareholder returns. The strongest expansion opportunities will align genuine patient demand with reliable, efficient care.<\/p>\n<h3>How investment assets support the insurer<\/h3>\n<p>Insurers hold financial assets to support liabilities and regulatory capital requirements. Investment income can contribute materially to reported profit, but the portfolio must be managed with liquidity and risk in mind. Medibank&#8217;s FY2025 net investment income of A$207.8 million increased from A$182.2 million. Market movements can affect this contribution even when the insurance operating business performs steadily. Management&#8217;s underlying profit calculation normalises certain investment effects, but statutory results remain relevant to shareholders.<\/p>\n<p>An investment portfolio is not a substitute for sound underwriting. Premium receipts come with obligations to pay future claims, and capital cannot be distributed freely without considering prudential requirements. The dividend policy must balance shareholder returns with resilience and future investment. Investors should monitor insurance operating profit, statutory profit, underlying profit and capital strength separately rather than relying on one headline number.<\/p>\n<p><strong>Source:<\/strong> <a href=\"https:\/\/www.medibank.com.au\/content\/dam\/retail\/about-assets\/pdfs\/investor-centre\/annual-reports\/Medibank_AnnualReport2025.pdf\">Medibank FY2025 Annual Report<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Medibank Private Business Model in 2026: Medibank, ahm, Amplar Health, financial performance and healthcare risks based on the FY2025 Annual Report.<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[166],"tags":[],"class_list":{"0":"post-27461","1":"post","2":"type-post","3":"status-publish","4":"format-standard","6":"category-business-model"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v20.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Medibank Private Business Model in 2026 - The Strategy Story<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/thestrategystory.com\/blog\/medibank-private-business-model-2026\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Medibank Private Business Model in 2026 - The Strategy Story\" \/>\n<meta property=\"og:description\" content=\"Medibank Private Business Model in 2026: Medibank, ahm, Amplar Health, financial performance and healthcare risks based on the FY2025 Annual Report.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/thestrategystory.com\/blog\/medibank-private-business-model-2026\/\" \/>\n<meta property=\"og:site_name\" content=\"The Strategy Story\" \/>\n<meta property=\"article:published_time\" content=\"2026-11-20T06:29:54+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-11-20T06:30:39+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/thestrategystory.com\/blog\/wp-content\/uploads\/2026\/03\/TSS-logo-11-modified.png\" \/>\n\t<meta property=\"og:image:width\" content=\"403\" \/>\n\t<meta property=\"og:image:height\" content=\"403\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Shikhar Goel\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Shikhar Goel\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"12 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/thestrategystory.com\/blog\/medibank-private-business-model-2026\/\",\"url\":\"https:\/\/thestrategystory.com\/blog\/medibank-private-business-model-2026\/\",\"name\":\"Medibank Private Business Model in 2026 - The Strategy Story\",\"isPartOf\":{\"@id\":\"https:\/\/thestrategystory.com\/blog\/#website\"},\"datePublished\":\"2026-11-20T06:29:54+00:00\",\"dateModified\":\"2026-11-20T06:30:39+00:00\",\"author\":{\"@id\":\"https:\/\/thestrategystory.com\/blog\/#\/schema\/person\/8eed62769b0125006923a7fdc33f1071\"},\"breadcrumb\":{\"@id\":\"https:\/\/thestrategystory.com\/blog\/medibank-private-business-model-2026\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/thestrategystory.com\/blog\/medibank-private-business-model-2026\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/thestrategystory.com\/blog\/medibank-private-business-model-2026\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/thestrategystory.com\/blog\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Medibank Private Business Model in 2026\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/thestrategystory.com\/blog\/#website\",\"url\":\"https:\/\/thestrategystory.com\/blog\/\",\"name\":\"The Strategy Story\",\"description\":\"Simplifying Business Strategies\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/thestrategystory.com\/blog\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/thestrategystory.com\/blog\/#\/schema\/person\/8eed62769b0125006923a7fdc33f1071\",\"name\":\"Shikhar Goel\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/thestrategystory.com\/blog\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/8b6c6c1213b8835c1731c5d95c1ea3103684847f09cc6d1aab64d3e432f66481?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/8b6c6c1213b8835c1731c5d95c1ea3103684847f09cc6d1aab64d3e432f66481?s=96&d=mm&r=g\",\"caption\":\"Shikhar Goel\"},\"url\":\"https:\/\/thestrategystory.com\/blog\/author\/tss-publisher\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Medibank Private Business Model in 2026 - The Strategy Story","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/thestrategystory.com\/blog\/medibank-private-business-model-2026\/","og_locale":"en_US","og_type":"article","og_title":"Medibank Private Business Model in 2026 - The Strategy Story","og_description":"Medibank Private Business Model in 2026: Medibank, ahm, Amplar Health, financial performance and healthcare risks based on the FY2025 Annual Report.","og_url":"https:\/\/thestrategystory.com\/blog\/medibank-private-business-model-2026\/","og_site_name":"The Strategy Story","article_published_time":"2026-11-20T06:29:54+00:00","article_modified_time":"2026-11-20T06:30:39+00:00","og_image":[{"width":403,"height":403,"url":"https:\/\/thestrategystory.com\/blog\/wp-content\/uploads\/2026\/03\/TSS-logo-11-modified.png","type":"image\/png"}],"author":"Shikhar Goel","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Shikhar Goel","Est. reading time":"12 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/thestrategystory.com\/blog\/medibank-private-business-model-2026\/","url":"https:\/\/thestrategystory.com\/blog\/medibank-private-business-model-2026\/","name":"Medibank Private Business Model in 2026 - The Strategy Story","isPartOf":{"@id":"https:\/\/thestrategystory.com\/blog\/#website"},"datePublished":"2026-11-20T06:29:54+00:00","dateModified":"2026-11-20T06:30:39+00:00","author":{"@id":"https:\/\/thestrategystory.com\/blog\/#\/schema\/person\/8eed62769b0125006923a7fdc33f1071"},"breadcrumb":{"@id":"https:\/\/thestrategystory.com\/blog\/medibank-private-business-model-2026\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/thestrategystory.com\/blog\/medibank-private-business-model-2026\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/thestrategystory.com\/blog\/medibank-private-business-model-2026\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/thestrategystory.com\/blog\/"},{"@type":"ListItem","position":2,"name":"Medibank Private Business Model in 2026"}]},{"@type":"WebSite","@id":"https:\/\/thestrategystory.com\/blog\/#website","url":"https:\/\/thestrategystory.com\/blog\/","name":"The Strategy Story","description":"Simplifying Business Strategies","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/thestrategystory.com\/blog\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/thestrategystory.com\/blog\/#\/schema\/person\/8eed62769b0125006923a7fdc33f1071","name":"Shikhar Goel","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/thestrategystory.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/8b6c6c1213b8835c1731c5d95c1ea3103684847f09cc6d1aab64d3e432f66481?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/8b6c6c1213b8835c1731c5d95c1ea3103684847f09cc6d1aab64d3e432f66481?s=96&d=mm&r=g","caption":"Shikhar Goel"},"url":"https:\/\/thestrategystory.com\/blog\/author\/tss-publisher\/"}]}},"_links":{"self":[{"href":"https:\/\/thestrategystory.com\/blog\/wp-json\/wp\/v2\/posts\/27461","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/thestrategystory.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/thestrategystory.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/thestrategystory.com\/blog\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/thestrategystory.com\/blog\/wp-json\/wp\/v2\/comments?post=27461"}],"version-history":[{"count":1,"href":"https:\/\/thestrategystory.com\/blog\/wp-json\/wp\/v2\/posts\/27461\/revisions"}],"predecessor-version":[{"id":27465,"href":"https:\/\/thestrategystory.com\/blog\/wp-json\/wp\/v2\/posts\/27461\/revisions\/27465"}],"wp:attachment":[{"href":"https:\/\/thestrategystory.com\/blog\/wp-json\/wp\/v2\/media?parent=27461"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/thestrategystory.com\/blog\/wp-json\/wp\/v2\/categories?post=27461"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/thestrategystory.com\/blog\/wp-json\/wp\/v2\/tags?post=27461"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}